SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000318306-14-000006
Filing Date
2014-03-26
Accepted
2014-03-26 17:01:41
Documents
12
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a10k-123113.htm 10-K 1137817
2 SUBSIDIARIES ex_21.htm EX-21 3911
3 AUDITORS CONSENT ex_23-1.htm EX-23.1 4064
4 CEO CERTIFICATION ex_31-1.htm EX-31.1 22518
5 CFO CERTIFICATION ex_31-2.htm EX-31.2 21294
6 CEO-CFO CERTIFICATION ex_32.htm EX-32 7842
  Complete submission text file 0000318306-14-000006.txt   7368387

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENTS accp-20131231.xml EX-101.INS 1071232
8 XBRL TAXONOMY SCHEMA accp-20131231.xsd EX-101.SCH 44032
9 XBRL CALCULATION LINKBASE accp-20131231_cal.xml EX-101.CAL 60818
10 XBRL DEFINITION LINKBASE accp-20131231_def.xml EX-101.DEF 232977
11 XBRL LABEL LINKBASE accp-20131231_lab.xml EX-101.LAB 673800
12 XBRL PRESENTATION LINKBASE accp-20131231_pre.xml EX-101.PRE 376744
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1025
Type: 10-K | Act: 34 | File No.: 001-15771 | Film No.: 14719277
SIC: 2834 Pharmaceutical Preparations